Sertraline
6 trials in this asset. Source: ClinicalTrials.gov, as of July 21, 2026.
Trials
6
Ongoing
0
Recruiting
0
Completed
6
Sites
15
Countries
3
Endpoints
32
Composite endpoints
0
Distinct sites and countries across this asset's trials. A site running several of its trials counts once, matching the map. All 32 linked ClinicalTrials.gov endpoints are classified into the categories below. Trial and endpoint linkage does not by itself establish treatment attribution for every endpoint.
Development
Where the program stands
Trials by phase
Trials by status
Evidence coverage
What this asset has been measured on
Endpoints grouped into outcome categories, ranked by how often they are measured across this asset's trials.
Most-measured metrics
Top 20 metrics across this asset's endpoints
Normalized metric codes are available for 2 of 32 classified ClinicalTrials.gov endpoints for this asset; the ranking below covers that coded subset.
2
Trials
Trials for this asset
Every trial for this asset, with the same search, filters, and sort as the Trials tab.
6 of 6
| Asset / Disease area | Key I/E criterion | Evidence | ||||||
|---|---|---|---|---|---|---|---|---|
| DESEPDementia Antipsychotics And Antidepressants Discontinuation Study | Citalopram, Escitalopram, Paroxetine, Risperidone, Sertraline Alzheimer’s disease, Vascular cognitive impairment / dementia | Multiple dementia etiologies | Ph 4 | Completed | 8 | Dec 2010 | 1 | |
| DIADS-2Depression in Alzheimer's Disease-2 | Sertraline Alzheimer’s disease | Alzheimer's disease | Ph 2/3 | Completed | 5 | Jul 2008 | 3 | results |
| CCICAMH - McMaster Collaborative Care Initiative For Mental Health Risk Factors In Dementia | Sertraline, Venlafaxine Mixed / unspecified dementia | Age 60-65 | Not applicable | Completed | 1 | Jul 2020 | 1 | |
| NCT00001777Sertraline for the Treatment of Patients With Frontal Lobe Dementia (FLD) | Sertraline Mixed / unspecified dementia | - | Ph 1 | Completed | 1 | May 2000 | 3 | |
| NCT00009191The Depression in Alzheimer's Disease Study (DIADS) | Sertraline Alzheimer’s disease | Alzheimer's disease | Ph 4 | Completed | 1 | Nov 2006 | 1 | |
| NCT00433121Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD | Citalopram, Escitalopram, Haloperidol, Olanzapine, Quetiapine, Risperidone, Sertraline Alzheimer’s disease, Vascular cognitive impairment / dementia | Multiple dementia etiologies | Ph 4 | Completed | 1 | Aug 2007 | - |
Showing 1-6 of 6 trials